Drug maker Valeant got a big profit boost from a one-time tax benefit and the company also boosted its EPS guidance and trimmed its revenue guidance for the full year.
Drug maker Valeant got a big profit boost from a one-time tax benefit and the company also boosted its EPS guidance and trimmed its revenue guidance for the full year.